Ipca Laboratories Ltd.
BSE: 524494 | Sector: Health care |
NSE: IPCALAB | ISIN Code: INE571A01038 |
BSE 12:40 | 03 Feb | 847.10 |
-9.40 (-1.10%) |
OPEN
858.15 |
HIGH
861.75 |
LOW
845.00 |
NSE 12:29 | 03 Feb | 847.75 |
-9.30 (-1.09%) |
OPEN
855.00 |
HIGH
863.50 |
LOW
844.85 |
OPEN | 858.15 |
PREVIOUS CLOSE | 856.50 |
VOLUME | 1213 |
52-Week high | 1089.00 |
52-Week low | 830.00 |
P/E | 33.58 |
Mkt Cap.(Rs cr) | 21,491 |
Buy Price | 846.00 |
Buy Qty | 12.00 |
Sell Price | 847.45 |
Sell Qty | 7.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ipca Laboratories Ltd. (IPCALAB) - Half Yearly Result
Particulars (![]() |
Sep '22 | Mar '22 | Sep '21 | Mar '21 | Sep '20 |
Net Sales/Income From Operations | 2954.16 | 2496.92 | 2902.44 | 2356.14 | 2783.02 |
Other Income | 55.40 | 27.45 | 28.68 | 35.56 | 26.68 |
Total Income | 3009.56 | 2524.37 | 2931.12 | 2391.70 | 2809.70 |
Total Expenditure | 2424.77 | 2006.38 | 2149.44 | 1790.67 | 1834.91 |
Operating Profit | 584.79 | 517.99 | 781.68 | 601.03 | 974.79 |
Interest | 15.80 | 4.48 | 2.73 | 3.87 | 4.27 |
Gross Profit | 568.99 | 513.51 | 778.95 | 597.16 | 970.52 |
Depreciation | 108.33 | 103.64 | 100.46 | 96.23 | 91.49 |
PBT | 460.66 | 409.87 | 678.49 | 500.93 | 879.03 |
Tax | 133.60 | 78.60 | 118.68 | 91.38 | 153.60 |
Net Profit/(Loss) | 311.60 | 328.58 | 542.36 | 411.45 | 729.32 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 311.60 | 328.58 | 542.36 | 411.45 | 729.32 |
Equity Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 4416.03 |
EPS | |||||
Basic EPS | 12.28 | 12.95 | 42.76 | 32.44 | 57.69 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Ipca Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices